Constellium N.V (NYSE:CSTM) is on recovery track with 126.26% gain from a 1-year low price of $5.025. The company lost -7.44% to attain the price of $11.2 on 10/31/2017. Throughout the recent session, the prices were hovering between $10.9 and $11.5825. These shares are 4.55% off its target price of $11.71 and the current market capitalization stands at $1.18B. The recent change has given its price a 4.94% lead over SMA 50 and -10.04% deficit over its 52-week high. The stock witnessed 8.74% gains, 34.94% gains and 58.87% gains for the 1-month, 3-month and 6-month period, respectively. To measure price-variation, we found CSTM’s volatility during a week at 6.58% and during a month it has been found around 4.54%.Constellium N.V (CSTM) Top Holders
Institutional investors currently hold around $720 million or 72.1% in CSTM stock. Look at its top three institutional owners. D. E. Shaw & Co., Inc. owns $63.35 million in Constellium N.V, which represents roughly 5.37% of the company’s market cap and approximately 8.8% of the institutional ownership. Similar statistics are true for the second largest owner, Vaughan Nelson Investment Management, L.P., which owns 4,575,975 shares of the stock are valued at $55.37 million. The third largest holder is Jennison Associates Llc, which currently holds $45.06 million worth of this stock and that ownership represents nearly 3.82% of its market capitalization.Constellium N.V 13F Filings
At the end of 06/30/2017 reporting period, 57 institutional holders increased their position in Constellium N.V (NYSE:CSTM) by some 8,335,022 shares, 66 decreased positions by 14,743,522 and 20 held positions by 36,386,381. That puts total institutional holdings at 59,464,925 shares, according to SEC filings. The stock grabbed 18 new institutional investments totaling 4,808,236 shares while 21 institutional investors sold out their entire positions totaling 6,134,425 shares.
Several analysts have released their opinion on Constellium N.V (NYSE:CSTM), with 3 analysts believing it is a strong buy. Whereas 4 of them predict the stock is a hold. Also, there are 0 buy, 0 sell and 0 strong sell ratings, collectively assigning a 2.14 average brokerage recommendation.